EVs derived from ticagrelor-pretreated H9c2 cells demonstrated an anti-apoptotic effect on hyperglycemia-induced cardiomyocytes through suppressing the expression of apoptotic genes, Bax and ENT1. This evidence concerns the gene SLC29A1 and Hyperglycemia.